Baxter 2B0296H - Dextrose Injection, 70% USP, 2000 ml, Viaflex Plastic Container, Pharmacy Bulk Package, 6/cs (Rx) (Continental US Only, Excluding IN and ND)
Baxter 2B0296H Dextrose Injection, 70% USP, 2000 ml, Viaflex Plastic Container
Dextrose Injection, USP is a sterile, nonpyrogenic solution for fluid replenishment and caloric supply in single dose containers for intravenous administration. It contains no antimicrobial agents. Composition, osmolarity, pH, and caloric content.
The flexible container is made with non-latex plastic materials specially designed for a wide range of parenteral drugs including those requiring delivery in containers made of polyolefins or polypropylene. For example, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of paclitaxel. In addition, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of all drugs deemed compatible with existing polyvinyl chloride container systems. The solution contact materials do not contain PVC, DEHP, or other plasticizers.
| Container Type | Latex Free | Size Millilitre | Product Use |
| Viaflex | Yes | 2000 ml | Parenteral Nutritional Support |
The suitability of the container materials has been established through biological evaluations, which have shown the container passes Class VI U.S. Pharmacopeia (USP) testing for plastic containers. These tests confirm the biological safety of the container system. The flexible container is a closed system, and air is prefilled in the container to facilitate drainage. The container does not require entry of external air during administration.
The VIAFLEX plastic container is fabricated from a specially formulated polyvinyl chloride (PL 146 Plastic). The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the plastic container can leach out certain of its chemical components in very small amounts within the expiration period, e.g., di-2-ethylhexyl phthalate (DEHP), up to 5 parts per million. However, the safety of the plastic has been confirmed in tests in animals according to USP biological test for plastic containers as well as by tissue culture toxicity studies.
Baxter 2B0296H Indications and Usage
Dextrose Injection, USP are indicated as a caloric component in a parenteral nutrition regimen. They are used with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: (1) the alimentary tract cannot or should not be used, (2) gastrointestinal absorption of protein is impaired, or (3) metabolic requirements for protein are substantially increased, as with extensive burns.
The infusion of hypertonic dextrose injections is contraindicated in patients having intracranial or intraspinal hemorrhage, in patients who are severely dehydrated, in patients who are anuric, and in patients in hepatic coma.
Baxter #2B0306, Sterile Water for Injection, USP, 2000 ml, Viaflex Plastic Container, for Drug Diluent Use Only, 6/cs (Rx) (Continental US Only, Excluding IN and ND)
Baxter #2B0010, Premasol (Amino Acid), Sulfite-Free, 10% Injection, 2000 ml, Viaflex Plastic Container, Not for Direct Infusion, Bulk, 6/cs (Rx) (Continental US Only, Excluding IN and ND)
Baxter #2B6189, Clinisol Injection, 15%, Sulfite-Free (Amino Acid), 2000 ml, Viaflex Plastic Container, Pharmacy Bulk Package, 6/cs (Rx) (Continental US Only, Excluding IN and ND)
